Long-Term Outcomes of Veteran Patients After Transcatheter Aortic Valve Replacement

Hani Jneid, Douglas Farmer, Riyad Y. Kherallah, David Paniagua, Ali Denktas, Biswajit Kar, Lorraine Cornwell, Alvin Blaustein, Ourania Preventza, Ernesto Jimenez

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


BACKGROUND: Transcatheter aortic valve replacement (TAVR) has become a mainstay treatment for severe aortic stenosis and is increasingly used for veterans, producing excellent short-term outcomes. There is a paucity of long-term outcome data after TAVR in the veteran population. METHODS: We examined consecutive patients who underwent TAVR at a single Veterans Affairs medical center through 2019. Baseline characteristics, echocardiographic and angiographic variables, and clinical outcomes were abstracted. All-cause mortality was the primary outcome of interest. Factors associated with all-cause mortality and cardiac-specific mortality, including the presence of significant non-revascularized coronary artery disease (CAD), were assessed with multivariable regression and competing-risk analyses. RESULTS: The 189 consecutive patients enrolled (mean age, 76.6 ± 8.4 years) had a median Society of Thoracic Surgeons (STS) score of 6.0 (interquartile range [IQR], 4.0-8.5). After a maximum follow-up of 7.5 years, 71 (37.6%) deaths occurred, of which 76% had a cardiac cause. Median overall survival was 3.55 years (95% confidence interval [CI], 3.21-5.30); significant graded differences were observed across STS risk subgroups (P<.001). After multivariable adjustment, CAD was significantly associated with cardiac mortality (hazard ratio [HR], 2.6; 95% CI, 1.3-5.3) and all-cause mortality (HR, 2.2; 95% CI, 1.1-4.3). Other independent variables associated with all-cause mortality included age (P=.01), baseline creatinine (P<.01), and chronic obstructive pulmonary disease (P=.03). Baseline ejection fraction (P=.04), age (P<.01), creatinine (P=.02), and vascular disease (P=.04) were independently associated with cardiac-specific mortality. CONCLUSION: Long-term survival of veterans after TAVR is comparable to that of their non-veteran counterparts. Significant CAD, along with age and select comorbidities, was associated with poorer survival.

Original languageEnglish (US)
Pages (from-to)E730-E737
JournalJournal of Invasive Cardiology
Issue number9
StatePublished - Sep 1 2021
Externally publishedYes


  • aortic valve replacement
  • coronary artery disease
  • outcomes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Long-Term Outcomes of Veteran Patients After Transcatheter Aortic Valve Replacement'. Together they form a unique fingerprint.

Cite this